> Detailanzeige

Hellfritzsch, Maja; Lund, Lars Christian; Ennis, Zandra; Stage, Tore; Damkier, Per; Bliddal, Mette; Jensen, Peter Bjødstrup; Henriksen, Daniel; Ernst, Martin Thomsen; Olesen, Morten; Broe, Anne; Kristensen, Kasper Bruun; Hallas, Jesper; Pottegård, Anton

Ischemic Stroke and Systemic Embolism in Warfarin Users With Atrial Fibrillation or Heart Valve Replacement Exposed to Dicloxacillin or Flucloxacillin

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel
  • Titel: Ischemic Stroke and Systemic Embolism in Warfarin Users With Atrial Fibrillation or Heart Valve Replacement Exposed to Dicloxacillin or Flucloxacillin
  • Beteiligte: Hellfritzsch, Maja; Lund, Lars Christian; Ennis, Zandra; Stage, Tore; Damkier, Per; Bliddal, Mette; Jensen, Peter Bjødstrup; Henriksen, Daniel; Ernst, Martin Thomsen; Olesen, Morten; Broe, Anne; Kristensen, Kasper Bruun; Hallas, Jesper; Pottegård, Anton
  • Erschienen: Wiley, 2020
  • Erschienen in: Clinical Pharmacology & Therapeutics, 107 (2020) 3, Seite 607-616
  • Sprache: Englisch
  • DOI: 10.1002/cpt.1662
  • ISSN: 0009-9236; 1532-6535
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: The antibiotics dicloxacillin and flucloxacillin induce cytochrome P450‐dependent metabolism of warfarin. We explored the influence of these drug–drug interactions on the clinical effectiveness of warfarin therapy due to atrial fibrillation or heart valve replacement. Using the population‐based Danish registers, we performed a propensity‐score matched cohort study including around 50,000 episodes of dicloxacillin/flucloxacillin matched to phenoxymethylpenicillin and to no antibiotic, respectively. We estimated hazard ratios (HRs) with 95% confidence intervals (CIs) by comparing 21‐day (days 7–28) risks of ischemic stroke/systemic embolism (SE) following initiation of each exposure. When compared with phenoxymethylpenicillin, dicloxacillin/flucloxacillin was associated with an HR of ischemic stroke/SE of 2.09 (95% CI 1.51–2.90; strongest for dicloxacillin (HR 2.17; 95% CI 1.56–3.02)). Use of an untreated comparator strengthened the association (HR 2.84; 95% CI 1.97–4.09). Dicloxacillin should be used with caution in patients receiving warfarin. This may also apply to flucloxacillin; however, more data on the risks associated with flucloxacillin exposure during warfarin therapy are needed.